Corticosteroid Injection of Chalazia

Castrén, J. A.; Stenborg, Tapio

doi:10.1111/j.1755-3768.1983.tb01477.x

Cited by 18 publications

(5 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Jacky W. Y. Lee et al, compare in there study the effect of Intralesional Triamcinolone Acetonide Injection for Primary Chalazion in Children and Adults found that a single injection of intralesional TA for the treatment of primary chalazion was equally effective in children and adults, without any significant complications, and the rate of clinical response did not appear to be dose-dependent.in our study all patients were adult and we have reached to the same conclusion regarding the influence of chalazion size and triamcinolone used dose in treatment procedure [2][3][4][5][6][7][8].…”

Section: Discussionsupporting

confidence: 60%

Intralesional Steroid Injection for Primary Chalazion in Adults

2020

JCRC

View full text Add to dashboard Cite

Background: Chalazion (Meibomian cyst) a chronic lipo-granulomatous inflammation seconday to retention of sebum caused by obstruction of Meibomian gland duct of unknown cause. It is manifested by localized painless swelling in upper or lower lid usually points towards conjunctival side of lid (to be differentiated from stye). Vary in presentation from a small painless nodule self-limiting to a painful lid swelling complicated by corneal astigmatism and mechanical ptosis. Treatment option in case 2ry infection is hot compresses and topical antibiotic and if large surgery excision (vertical incision into the tarsal gland from conjunctiva surface). Injection of steroid (Triamcinolone) inside Chalazion considered as alternative treatment option with high success rate particularly in patients where incision and curette is difficult to perform due to poor patient’s cooperation. Or risk of lacrimal passage injury when the lesion located near to it... The aim of this study is to assess the effectiveness of intralesional triamcinolone acetonide (TA) injection for the treatment of primary chalazion in adults. Methods: 24 adult Patients mean age 38.6 ± 13.2 years with primary chalazion subjected to intralesional triamcinolone injection as management of primary chalazion. 0.05 to 0.15mL of triamcinolone injected into the center of the chalazion transconjunctivally in three patients the eversion of the upper lid were difficult and the injection was given transcutaneous. Result: 15 females and 9 males were included in this study. right eye was more affected than the left side14/10 respectively in all cases chalazion locate in the upper lid, mean chalazion size 0.74 ± 0.4 mm², time for complete resolution of the chalazion17.5 ± 12.0 days. There were no significant complications reported from this procedure Conclusion: Intralesional triamcinolone acetonide (TA) injection for the treatment of primary chalazion in adult was effective and without any significant complications.

show abstract

Section: Discussionsupporting

confidence: 60%

Intralesional Steroid Injection for Primary Chalazion in Adults

2020

JCRC

View full text Add to dashboard Cite

show abstract

“…Serious complications of steroid injections, including skin depigmentation, fundus vascular occlusion, post-injection hemorrhage and inadvertent globe penetration, are rare 42 – 45 . Surgical incision may be suitable for large or infected chalazion or lesions that do not respond to conservative treatment 46 . However, permanent eyelid dysfunction and aesthetic flaws may arise from eyelid marginal and numerous incisions for recurring chalazion.…”

Section: Discussionmentioning

confidence: 99%

Novel treatment of chalazion using light-guided-tip intense pulsed light

Zhu,

Zhao,

Huang

et al. 2023

Sci Rep

View full text Add to dashboard Cite

We assessed the effectiveness of light-guided-tip intense pulsed light (IPL) with meibomian gland expression (MGX) in chalazion treatment. Ninety-five eyes with chalazion received a light-guided-tip IPL-MGX treatment (IPL-MGX group), and another 95 eyes with chalazion received incision with curettage treatment (Control group). Prior to IPL or incision, as well as 1 month after the final treatment, data were gathered pertaining to the lesion location and size, hyperemia, lesions regression or recurrence, and a comprehensive ophthalmic examination. The total size of the chalazia in the IPL-MGX group was significantly reduced after the final treatment, with an average resolution rate of 70.5%, which is comparable to excision surgery. A significant decrease in chalazion recurrence rate was apparent after treatment in the IPL-MGX group compared with control. Moreover, the IPL-MGX demonstrated significant advancements throughout noninvasive tear film breakup time (NIBUT) as well as meibum grade in comparison to baseline and those in the the Control group. The use of IPL-MGX was found to be an efficient therapy for reducing the size and recurring frequency of chalazia, as well as for improving the meibomian gland function. It may be considered as a first-line treatment for cases of primary or recurrent chalazia with inflammation.

show abstract

“…1,3 The choice of treatment of chalazion is usually based on clinical experience as was observed in this study, but it is important to note that the cytopathologic appearance of the chalazion granuloma, whether it is a mixed cell or a suppurating type, may also determine the choice of 4, 9 treatment. 4,16 Chalazion can be treated conservatively using an intralesional injection of long-acting corticosteroid, 17,18,19 surgery in the form of incision and curettage or 13 subconjunctival total excision of the chalazion or a 20 combination of surgery with intralesional injection. In our 4,16 centre, incision and curettage are the standard methods of treatment and these were administered in 74.6% of the cases.…”

Section: Discussionmentioning

confidence: 99%

Chalazion, a Benign Eyelid Tumour – The Sagamu Experience

Otulana¹,

Bodunde²,

Ajibode³

2009

Nigerian Journal of Ophthalmology

View full text Add to dashboard Cite

Aim: To study the demographic characteristics, pattern of presentation and type of treatment of chalazion in Sagamu, Nigeria. Materials and Methods: A retrospective hospital-based study was conducted to review all the cases seen and diagnosed as chalazion in the eye clinic of Olabisi Onabanjo University Teaching Hospital [OOUTH], Sagamu between January 1997 and December 2007. Data was obtained from the clinic attendance register, the register of minor office procedure and the case files. The age, sex, pattern of presentation and type of treatment given were recorded. Result: Ninety-seven cases (0.7%) out of a total of 13,605 new cases seen during the period under review were diagnosed as chalazion although 59 case records were available for review. There were 46 males and 51 females with a mean age of 25.3 years. Thirty-nine cases (40.2%) were between the ages of 21 and 30 years. Twenty-one cases (42.9%) presented with multiple chalazia while 32 cases (65.3%) had chalazion only in their upper eyelids. Forty-four cases (74.6%) were treated with incision and curettage. Conclusion: Chalazion is not a common ocular problem. Young age at presentation and multiple lesions are significant findings. Surgery is the standard method of treatment.

show abstract

Corticosteroid Injection of Chalazia

Cited by 18 publications

References 5 publications

Intralesional Steroid Injection for Primary Chalazion in Adults

Intralesional Steroid Injection for Primary Chalazion in Adults

Novel treatment of chalazion using light-guided-tip intense pulsed light

Chalazion, a Benign Eyelid Tumour – The Sagamu Experience

Contact Info

Product

Resources

About